F/M Emerald Life Sciences Innovation ETF (LFSC) Price

The ISIN of F/M Emerald Life Sciences Innovation ETF is US74933W2219.

The total expense ratio of F/M Emerald Life Sciences Innovation ETF is 0.54%, which means that investors pay 54.00 USD per 10,000 USD in investment capital annually.

The ETF is listed in USD.

European investors may incur additional costs for currency exchange and transaction fees.

No, F/M Emerald Life Sciences Innovation ETF does not comply with the EU UCITS investor protection directives.

The current average trading volume of F/M Emerald Life Sciences Innovation ETF is 6,280.61.

F/M Emerald Life Sciences Innovation ETF is domiciled in US.

The fund was launched on 10/30/2024.

The F/M Emerald Life Sciences Innovation ETF mainly invests in Healthcare companies.

The NAV of F/M Emerald Life Sciences Innovation ETF amounts to 34.94 M USD.

The price-to-book ratio is 6.27.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.